Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stryker M&A Strategy Intact Under New CEO With Latest Deal For Stroke Care

This article was originally published in The Gray Sheet

Executive Summary

Purchase of Surpass Medical for $135 million represents Stryker’s 10th acquisition since 2009. The company affirmed its acquisition strategy focused on core and key adjacent markets during its Oct. 17 earnings call, but also sought to ratchet down earnings growth expectations in the near term to account for headwinds, including the upcoming U.S. medical device excise tax.


Related Content

Global Device Approvals, Weekly Snapshot: July 9-15, 2018
Device/Diagnostics Quarterly Deal Statistics, Q4 2012
Market & Industry Briefs, November 2012
People In Brief
Stryker Debuts Next-Gen Clot Remover For Ischemic Stroke, Boosting Neuro Competition
Stryker Buys Concentric Medical To Enter Acute Ischemic Stroke Market
Stryker Buys Target Neurovascular Biz From Boston Scientific For $1.5 Billion





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts